1. Home
  2. CLW vs WHWK Comparison

CLW vs WHWK Comparison

Compare CLW & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clearwater Paper Corporation

CLW

Clearwater Paper Corporation

HOLD

Current Price

$16.51

Market Cap

216.4M

ML Signal

HOLD

WHWK

Whitehawk Therapeutics Inc.

HOLD

Current Price

$4.02

Market Cap

233.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLW
WHWK
Founded
1926
2007
Country
United States
United States
Employees
3710
23
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
216.4M
233.4M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CLW
WHWK
Price
$16.51
$4.02
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$20.33
$7.50
AVG Volume (30 Days)
185.5K
446.8K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,555,400,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.42
N/A
52 Week Low
$11.73
$1.57
52 Week High
$30.96
$5.50

Technical Indicators

Market Signals
Indicator
CLW
WHWK
Relative Strength Index (RSI) 61.78 45.02
Support Level $12.09 $3.72
Resistance Level $16.97 $4.38
Average True Range (ATR) 0.73 0.32
MACD 0.09 -0.08
Stochastic Oscillator 80.52 6.40

Price Performance

Historical Comparison
CLW
WHWK

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.

About WHWK Whitehawk Therapeutics Inc.

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

Share on Social Networks: